Oncopharmpod
CodeBreak200 And Elderly AML Survival
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:19:58
- Mas informaciones
Informações:
Sinopsis
CodeBreak200: docetaxel vs. sotorasib in 2nd-line metastatic NSCLC (KRAS-G12C). A new safety signal emerges. https://doi.org/10.1016/S0140-6736(23)00221-0 A new survival prediction model for elderly patients with AML not receiving intensive therapy. https://doi.org/10.1002/cncr.34609
